MANE
Veradermics, Incorporated
116.80$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Veradermics, Incorporated (MANE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -14 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| -3.6 | -13 | -16 | -19 | -24 | -21 | -14 | -78 | |
| 0.1 | 0.2 | 0.1 | 0.1 | 1.0 | 5.3 | 3.5 | 9.9 | |
| 0.8 | -1.5 | -0.4 | 0.6 | -2.6 | 0.3 | 0.0 | -1.8 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | 15 | -110 | -101 | -277 | -473 | |
| -2.5 | – | – | – | 0.0 | – | – | – | |
| 50 | 8.4 | 0.1 | 1.1 | 150 | 269 | 443 | 862 | |
| 47 | -21 | -24 | -2.9 | 16 | 147 | 151 | 311 | |
| -3.6 | -13 | -16 | -19 | -24 | -21 | -15 | -78 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.